L
Lucira Health Inc
NASDAQ:LHDX
Lucira Health Inc
NASDAQ:LHDX
Price:
0.0339 USD
-19.29%
Updated:
May 6, 2024
Lucira Health Inc
Cash from Financing Activities
|
Lucira Health Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
L
|
Lucira Health Inc
NASDAQ:LHDX
|
Cash from Financing Activities
$161.7m
|
CAGR 3-Years
250%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Lucira Health Inc's Cash from Financing Activities?
Cash from Financing Activities
161.7m
USD
161.7m
USD
Based on the financial report for Dec 31, 2021, Lucira Health Inc's Cash from Financing Activities amounts to 161.7m USD.
What is Lucira Health Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
250%
250%
Over the last year, the Cash from Financing Activities growth was 50%. The average annual Cash from Financing Activities growth rates for Lucira Health Inc have been 250% over the past three years .
You don't have any saved screeners yet
